ConvaTec
UK medical products and technologies company
London SE
ISIN GB00BD3VFW73 LEI 213800LS272L4FIDOH92
Follow ConvaTec
Weekly email: filings, results
Revenue, last year
$2.4B
+6.5% vs prior year
Net income
$175M
−8.1% vs prior year
EPS, diluted
$0.09
−7.5% vs prior year
Operating cash flow
$470M
+18.6% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.4B | $175M |
| FY24 | $2.3B | $190.5M |
| FY23 | $2.1B | $130.3M |
| FY22 | $2.1B | $62.9M |
| FY21 | $2B | $117.6M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 56.2% | 13% | 7.2% |
| FY24 | 56.1% | 14.2% | 8.3% |
| FY23 | 56% | 12.3% | 6.1% |
| FY22 | 53.3% | 10% | 3% |
| FY21 | 55.1% | 10% | 5.8% |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $140M | $326M |
| FY24 | $130.2M | $10.9M |
| FY23 | $110.7M | - |
| FY22 | $88.1M | - |
| FY21 | $85.8M | - |